Network-based sub-network signatures unveil the potential for acute myeloid leukemia therapy.
about
ColoFinder: a prognostic 9-gene signature improves prognosis for 871 stage II and III colorectal cancer patients.SNRFCB: sub-network based random forest classifier for predicting chemotherapy benefit on survival for cancer treatment.Identification of potential tissue-specific cancer biomarkers and development of cancer versus normal genomic classifiers.
P2860
Network-based sub-network signatures unveil the potential for acute myeloid leukemia therapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Network-based sub-network sign ...... cute myeloid leukemia therapy.
@en
Network-based sub-network sign ...... cute myeloid leukemia therapy.
@nl
type
label
Network-based sub-network sign ...... cute myeloid leukemia therapy.
@en
Network-based sub-network sign ...... cute myeloid leukemia therapy.
@nl
prefLabel
Network-based sub-network sign ...... cute myeloid leukemia therapy.
@en
Network-based sub-network sign ...... cute myeloid leukemia therapy.
@nl
P2093
P2860
P356
P1433
P1476
Network-based sub-network sign ...... cute myeloid leukemia therapy.
@en
P2093
P2860
P304
P356
10.1039/C4MB00440J
P577
2014-12-01T00:00:00Z